ARCHIVES

BMS Settles Charges Of Obstructing Generics

This article is from The Cancer Letter archive.

Vol. 29 No. 11 | March 14, 2003

Download PDF Visit The Full Archive

Related Articles

Guest Editorial: Group Chairs Urge Implementation of NCI plan. Next Step: Bioinformatics and Tissue Banks

November 11, 2011

ORI Misconduct Findings Announced In Two Cases

July 12, 1996

Immunotherapy Shrinks Tumors In Phase I Study at St. Jude

May 30, 2014

NCI Director Broder, Going On 3rd Year, Examines Issues Of Funding, Priorities, For Institute’s Future

September 20, 1991

Caris Life Sciences Lays Off Estimated 20 Percent of Staff

October 24, 2014

Clinton Signs Bill Creating NIH Center On Minority Health.

December 1, 2000